Risk-Based Monitoring in Clinical Trials: Summary Report 

ACRO’s 2021 RBQM Summary Report highlights the key takeaways from ACRO’s RBQM survey, outlining the current state of RBM & RBQM in the clinical research industry.

You can find full results and in-depth discussion in ACRO’s January 2023 publication, Risk-Based Monitoring in Clinical Trials: 2021 Update.

A Survey of ACRO Member Companies Shows How Risk-Based Approaches Are Used in Clinical Trials

Scroll to Top